Clinical Trial Update: Evolut™ EXPAND TAVR II Pivotal Trial [NA]

View source ↗

Summary

Medtronic's Evolut EXPAND TAVR II pivotal trial for moderate aortic valve stenosis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• Evolut Transcatheter Aortic Valve

Snippet

Sponsor: Medtronic Cardiovascular | Conditions: Moderate Aortic Valve Stenosis | NA | Status: ACTIVE_NOT_RECRUITING